The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Aspirin triggers antiinflammatory 15-epi-lipoxin A 4 and inhibits thromboxane in a randomized human trial
Open accessAbstract
There is increasing evidence that aspirin initiates biosynthesis of novel antiinflammatory mediators by means of interactions between endothelial cells and leukocytes. These mediators are classified as aspirin-triggered 15-epi-lipoxins. Such compounds may account at least in part for aspirin's clinical benefits, which are distinct from the well appreciated action of aspirin as a platelet inhibitor. Here, we addressed whether aspirin-triggered 15-epilipoxinA 4 (ATL) formation is aspirin-dependent in humans and its relationship to aspirin's antiplatelet activity. We conducted a randomized clinical trial among 128 healthy subjects allocated to placebo or to 81-, 325-, or 650-mg daily doses of aspirin for 8 weeks. Plasma thromboxane (TX)B 2 , an indicator of platelet reactivity, and ATL were assessed from blood collected at baseline and at 8 weeks. Plasma ATL levels significantly increased in the 81-mg aspirin group (0.25 ± 0.63 ng/ml, P = 0.04), with borderline increases in the 325-mg group (0.16 ± 0.71 ng/ml) and no apparent significant changes in the 650-mg group (0.01 ± 0.75 ng/ml, P = 0.96). When ATL and TXB 2 were compared, levels changed in a statistically significant and opposite direction ( P < 0.01) for all three aspirin doses. These results demonstrated that low-dose aspirin (81 mg daily) initiates production of antiinflammatory ATL opposite to the inhibition of TX. Monitoring ATL may represent a simple clinical parameter to verify an individual's vascular leukocyte antiinflammatory response with low-dose aspirin treatment. These results also emphasize the importance of cell-cell interactions in the modulation of hemostatic, thrombotic, and inflammatory processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationBombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationAltman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationNonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationTopper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 700
Self-citationRocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., & Patrono, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112202999 · Cited by 317
Weissmann, G. (1991) · Scientific American · doi:10.1038/scientificamerican0191-84 · Cited by 229
Clària, J., Lee, M. H., & Serhan, C. N. (1996) · Molecular Medicine · doi:10.1007/bf03401642 · Cited by 192
Self-citationAspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
Sanak, M., Levy, B. D., Clish, C. B., Chiang, N., Gronert, K., Mastalerz, L., Serhan, C. N., & Szczeklik, A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16a08.x · Cited by 174
Self-citationBrimhall, G. H. (1991) · Scientific American · doi:10.1038/scientificamerican0591-84 · Cited by 156
Evidence for Prothrombotic Effects of Exercise and Limited Protection by Aspirin
Li, N., Wallén, N. H., & Hjemdahl, P. (1999) · Circulation · doi:10.1161/01.cir.100.13.1374 · Cited by 140
Cyclooxygenase-2–derived lipoxin A4 increases gastric resistance to aspirin-induced damage
Fiorucci, S., de Lima, O. M., Mencarelli, A., Palazzetti, B., Distrutti, E., McKnight, W., Dicay, M. S., Ma, L., Romano, M., Morelli, A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36558 · Cited by 137
Chiang, N., Takano, T., Clish, C. B., Petasis, N. A., Tai, H., & Serhan, C. N. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37857-7 · Cited by 102
Self-citationParsing an enigma: the pharmacodynamics of aspirin resistance
FitzGerald, G. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12560-3 · Cited by 80
Targets for Antiinflammatory Drugs
Cronstein, B. N., & Weissmann, G. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002313 · Cited by 71
Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures
Nobelstiftelsen (1982) · Almqvist & Wiksell International eBooks · Cited by 70
COX Inhibitors and Thromboregulation
Marcus, A. J., Broekman, M. J., & Pinsky, D. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr021805 · Cited by 69
Fiorucci, S., Distrutti, E., de Lima, O. M., Romano, M., Mencarelli, A., Barbanti, M., Palazzini, E., Morelli, A., & Wallace, J. L. (2003) · The FASEB Journal · doi:10.1096/fj.02-0777fje · Cited by 62
Physical exercise increases urinary excretion of lipoxin A 4 and related compounds
Gangemi, S., Luciotti, G., D’Urbano, E., Mallamace, A., Santoro, D., Bellinghieri, G., Davı̀, G., & Romano, M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01004.2002 · Cited by 61
What are all the things that aspirin does?
Flower, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7415.572 · Cited by 60
Lipoxins: Pro-resolution lipid mediators in intestinal inflammation
Goh, J., Godson, C., Brady, H. R., & MacMathúna, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50154 · Cited by 54
Endogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution
Serhan, C. N. (2002) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1568014023355881 · Cited by 31
Self-citation
Cited by
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationPsychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,703
Emerging targets in neuroinflammation-driven chronic pain
Ji, R.-R., Xu, Z.-Z., & Gao, Y.-J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4334 · Cited by 1,101
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Self-citationResolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
Metadata
- Authors
- Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-10-07
- Volume
- 101
- Issue
- 42
- Pages
- 15178-15183
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2162592603
- Cited by
- 266
- References
- 33
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.